CLOVER HEALTH: Joins FDA's Early Payor Feedback Program to Encourage Innovation Among Medical Device Makers
Clover's technology-first approach brings a new perspective to group of legacy payors
Latest News
PTC THERAPEUTICS: Announces First Commercial Milestone Payment Following U.S. FDA Approval of Evrysdi™ (risdiplam)
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that the company achieved a $20 million milestone payment from Roche under its License and Collaboration Agreement.
BEARPAC MEDICAL: Announces Commercial Launch of the New Passio Pump Drainage System After Receiving FDA 510(k) Clearance
Bearpac Medical, LLC is pleased to announce that they have launched a new FDA 510(k) cleared device intended to treat patients with malignant and other recurrent pleural effusions.
FDA: Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19
As part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to include treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19, irrespective of their